This federal contract award is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OLUMIANT 4 MG TABLET 30S. The Firm Fixed Price contract has a ceiling value of $14,798.55 and a period of performance through June 6, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,397.99, is for the delivery of OLUMIANT 2 MG TABLET 30S, a medication used in the treatment of certain medical conditions. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,476.62, is for the delivery of OLUMIANT 4 MG TABLET 30S, a medication used to treat certain medical conditions. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of OLUMIANT 2 MG TABLET 30S, with a ceiling value of $7,731.75 and a performance period ending on May 22, 2025. The contract is a firm fixed price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a Delivery Order valued at $4,043.48 issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a completion date of May 30, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,962.58 and a completion date of January 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, and it is part...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $1,023.41 and an ultimate completion date of August 29, 2024. The contract is a Firm Fixed Price type and has no set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, valued at $19,019.85, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, with a period of performance through June 16, 2025. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $82,443.07 for the delivery of Olumiant 4 mg tablets. The contract has a period of performance through September 25, 2024 and is structured as a firm-fixed-price arrangement. This delivery order is placed against an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific contract award is for the delivery of 4567156621 - OLUMIANT 4 MG...